Manuel Bellver Oliver1, Javier Escrig-Sos2, Fernando Rotellar Sastre3, Ángel Moya-Herráiz2, Luis Sabater-Ortí4. 1. Department of Surgery, HPB Unit, Hospital General Universitario Castellón, Jaume I University, Castellón de la Plana, Spain. mbellver@icloud.com. 2. Department of Surgery, HPB Unit, Hospital General Universitario Castellón, Jaume I University, Castellón de la Plana, Spain. 3. HPB and Liver Transplant Unit, General and Digestive Surgery, University Clinic of Navarra, University of Navarra, Pamplona, Spain. 4. Department of Surgery, Biomedical Research Institute INCLIVA, Hospital Clínico, University of Valencia, Valencia, Spain.
Abstract
PURPOSE: Liver metastases are the most common malignant solid liver lesions, approximately 40% of which stem from colorectal tumors. Liver resection is currently the only curative treatment for colorectal cancer liver metastases (CRLM). However, there is a lack of consensus criteria to assess the results of this treatment. In order to evaluate the quality of surgical outcomes, it is necessary to identify quality indicators (QIs) and their corresponding quality standards (QS). We propose a simple method to determine QI and QS in CRLM surgery (CRLMS) and establish acceptable quality limits (AQL) for each QI. MATERIAL AND METHODS: A systematic review of CRLMS results published from 2006 to 2016. Clinical guidelines, consensus conferences, and publications related to the CRLMS were reviewed to identify and select QIs. Once selected, a new review of the papers including the results of at least one of the QIs was performed. Statistical process control (SPC) method was applied to calculate the QS and AQL of each QI. The limits of variability were established from mean and confidence intervals at 95% and 99.8%. RESULTS: The most relevant QIs and its AQLs were postoperative mortality (2%, < 4.5%), overall postoperative morbidity (33%, < 41%), liver failure (5%, < 8%), postoperative hemorrhage (1%, < 3%), biliary fistula (6%, < 10%), reoperation (3%, < 6%), R1 resection margins (18%, < 25%), and overall survival at 12 and 60 months (84%, > 77%; and 34%, > 25%, respectively). CONCLUSIONS: Despite its limitations, the present study constitutes the most extensive scientific evidence to date on QI and AQL in CRLMS and may constitute a reference in future studies.
PURPOSE: Liver metastases are the most common malignant solid liver lesions, approximately 40% of which stem from colorectal tumors. Liver resection is currently the only curative treatment for colorectal cancer liver metastases (CRLM). However, there is a lack of consensus criteria to assess the results of this treatment. In order to evaluate the quality of surgical outcomes, it is necessary to identify quality indicators (QIs) and their corresponding quality standards (QS). We propose a simple method to determine QI and QS in CRLM surgery (CRLMS) and establish acceptable quality limits (AQL) for each QI. MATERIAL AND METHODS: A systematic review of CRLMS results published from 2006 to 2016. Clinical guidelines, consensus conferences, and publications related to the CRLMS were reviewed to identify and select QIs. Once selected, a new review of the papers including the results of at least one of the QIs was performed. Statistical process control (SPC) method was applied to calculate the QS and AQL of each QI. The limits of variability were established from mean and confidence intervals at 95% and 99.8%. RESULTS: The most relevant QIs and its AQLs were postoperative mortality (2%, < 4.5%), overall postoperative morbidity (33%, < 41%), liver failure (5%, < 8%), postoperative hemorrhage (1%, < 3%), biliary fistula (6%, < 10%), reoperation (3%, < 6%), R1 resection margins (18%, < 25%), and overall survival at 12 and 60 months (84%, > 77%; and 34%, > 25%, respectively). CONCLUSIONS: Despite its limitations, the present study constitutes the most extensive scientific evidence to date on QI and AQL in CRLMS and may constitute a reference in future studies.
Authors: Peter J Kneuertz; Henry A Pitt; Karl Y Bilimoria; Jill P Smiley; Mark E Cohen; Clifford Y Ko; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2012-07-04 Impact factor: 3.452
Authors: Douglas Quan; Steven Gallinger; Cindy Nhan; Rebecca A Auer; James J Biagi; Glenn G Fletcher; Calvin H L Law; Carol-Anne E Moulton; Leyo Ruo; Alice C Wei; Robin S McLeod Journal: Surgery Date: 2012-02-07 Impact factor: 3.982
Authors: Luis Sabater; Alvaro García-Granero; Javier Escrig-Sos; Maria Del Carmen Gómez-Mateo; Juan Sastre; Antonio Ferrández; Joaquín Ortega Journal: Ann Surg Oncol Date: 2014-01-06 Impact factor: 5.344
Authors: Emmanuel Melloul; Martin Hübner; Michael Scott; Chris Snowden; James Prentis; Cornelis H C Dejong; O James Garden; Olivier Farges; Norihiro Kokudo; Jean-Nicolas Vauthey; Pierre-Alain Clavien; Nicolas Demartines Journal: World J Surg Date: 2016-10 Impact factor: 3.352
Authors: Henner M Schmidt; Susanne S Gisbertz; Johnny Moons; Ioannis Rouvelas; Juha Kauppi; Andrew Brown; Emanuele Asti; Misha Luyer; Sjoerd M Lagarde; Felix Berlth; Annouck Philippron; Christiane Bruns; Arnulf Hölscher; Paul M Schneider; Dimitri A Raptis; Mark I van Berge Henegouwen; Philippe Nafteux; Magnus Nilsson; Jari Räsanen; Francesco Palazzo; Ernest Rosato; Stuart Mercer; Luigi Bonavina; Grard Nieuwenhuijzen; Bas P L Wijnhoven; Wolfgang Schröder; Piet Pattyn; Peter P Grimminger; Christian A Gutschow Journal: Ann Surg Date: 2017-11 Impact factor: 12.969
Authors: S Bipat; M S van Leeuwen; J N M Ijzermans; E F I Comans; A S Th Planting; P M M Bossuyt; J-W Greve; J Stoker Journal: Neth J Med Date: 2007-01 Impact factor: 1.422
Authors: Xavier Muller; Francesca Marcon; Gonzalo Sapisochin; Max Marquez; Federica Dondero; Michel Rayar; Majella M B Doyle; Lauren Callans; Jun Li; Greg Nowak; Marc-Antoine Allard; Ina Jochmans; Kyle Jacskon; Magali Chahdi Beltrame; Marjolein van Reeven; Samuele Iesari; Alessandro Cucchetti; Hemant Sharma; Roxane D Staiger; Dimitri A Raptis; Henrik Petrowsky; Michelle de Oliveira; Roberto Hernandez-Alejandro; Antonio D Pinna; Jan Lerut; Wojciech G Polak; Eduardo de Santibañes; Martín de Santibañes; Andrew M Cameron; Jacques Pirenne; Daniel Cherqui; René A Adam; Bö-Göran Ericzon; Bjoern Nashan; Kim Olthoff; Avi Shaked; William C Chapman; Karim Boudjema; Olivier Soubrane; Catherine Paugam-Burtz; Paul D Greig; David R Grant; Amanda Carvalheiro; Paolo Muiesan; Philipp Dutkowski; Milo Puhan; Pierre-Alain Clavien Journal: Ann Surg Date: 2018-03 Impact factor: 12.969